Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN29572296) titled 'Glimepiride versus gliclazide modified-release in type 2 diabetes patients fasting during Ramadan in Iraq' on March 6.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Blinded (masking used)
Control: Active
Assignment: Parallel
Purpose: Diagnostic, Screening, Treatment
Primary Sponsor: Thi Qar University
Condition:
Type 2 diabetes mellitus (T2DM) in the context of Ramadan fasting
Nutritional, Metabolic, Endocrine
Intervention:
Participants in both groups received their pre-existing, physician-prescribed oral sulfonylurea therapy unchanged throughout the study pe...